Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptides and proteins are fundamental biological macromolecules consisting of amino acids linked by peptide bonds, performing a vast array of functions including enzymatic catalysis, structural support, and cell signaling (MedlinePlus, 2021). While they constitute the majority of known drug targets, such as G protein-coupled receptors and kinases, the collective term Peptides and proteins is a broad chemical classification rather than a specific, actionable therapeutic target (Nature Education, 2014). In drug development, these molecules are often categorized as biologics when used as therapeutics, or as the proteome when referring to the entire set of proteins expressed by a genome (NCBI, 2023). Because this category encompasses thousands of distinct functional entities with diverse roles in health and disease, it lacks the specificity needed for pharmacological characterization. Therefore, this entry is considered incorrect for target annotation purposes, as it represents a high-level molecular class rather than a single receptor or enzyme (IUPHAR/BPS Guide to Pharmacology, 2024).
Not applicable as this is a broad molecular class rather than a specific therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptides and proteins.